E-LIB Suche - Ergebnisse für: Iannazzo, Sergio

1

Efgartigimod and Ravulizumab for Treating Acetylcholine Rec..:

van Steen, Cécile ; Celico, Lorenzo ; Spaepen, Erik...
Advances in Therapy. 41 (2024) 6 - p. 2486-2499 , 2024

Link: https://doi.org/10.1007/..

2

Association Between Myasthenia Gravis–Activities of Daily L..:

Dewilde, Sarah ; Qi, Cynthia Z. ; Phillips, Glenn..
Advances in Therapy. 40 (2023) 4 - p. 1818-1829 , 2023

Link: https://doi.org/10.1007/..

3

A comparative analysis of international health technology a..:

Iannazzo, Sergio
Global & Regional Health Technology Assessment. 8 (2021) - p. 14-21 , 2021

Link: https://doi.org/10.33393..

4

Clinical efficacy comparison of avapritinib with other tyro..:

von Mehren, Margaret ; Heinrich, Michael C. ; Shi, Hongliang...
BMC Cancer. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

5

Cost‐analysis of persistent hyperkalaemia in non‐dialysis c..:

Provenzano, Michele ; De Francesco, Maria ; Iannazzo, Sergio...
International Journal of Clinical Practice. 74 (2020) 5 - p. , 2020

Link: https://doi.org/10.1111/..

6

An Integrated Management Model of Patients With Atrial Fibr..:

Casolo, Giancarlo ; Cavirani, Giuseppe ; Del Carlo, Alessandro...
Farmeconomia. Health economics and therapeutic pathways. 20 (2019) 1S - p. , 2019

Link: https://doi.org/10.7175/..

7

Systematic review: economic evaluations of HCV screening in..:

Cortesi, Paolo Angelo ; Barca, Roberta ; Giudicatti, Giulia...
Alimentary Pharmacology & Therapeutics. 49 (2019) 9 - p. 1126-1133 , 2019

Link: https://doi.org/10.1111/..

8

Cost Effectiveness of the Third-Generation Tyrosine Kinase ..:

Hirt, Carsten ; Iannazzo, Sergio ; Chiroli, Silvia...
Applied Health Economics and Health Policy. 17 (2019) 4 - p. 555-567 , 2019

Link: https://doi.org/10.1007/..

9

Cost-Effectiveness Analysis of Peginterferon Beta-1a in the..:

Centonze, Diego ; Iannazzo, Sergio ; Santoni, Laura...
Farmeconomia. Health economics and therapeutic pathways. 19 (2018) 1 - p. , 2018

Link: https://doi.org/10.7175/..

10

A Decision-Analytic Model to Assess the Cost-Effectiveness ..:

Stollenwerk, Björn ; Iannazzo, Sergio ; Akehurst, Ron...
PharmacoEconomics. 36 (2018) 5 - p. 603-612 , 2018

Link: https://doi.org/10.1007/..

11

Number-Needed-To-Treat (NNT) and Cost of Responses Achieved..:

Levy, Moshe Y. ; McGarry, Lisa ; Iannazzo, Sergio..
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) - p. S310 , 2017

Link: https://doi.org/10.1016/..

12

Cost-effectiveness analysis of empagliflozin in the treatme..:

Iannazzo, Sergio ; Mannucci, Edoardo ; Reifsnider, Odette.
Farmeconomia. Health economics and therapeutic pathways. 18 (2017) 1 - p. , 2017

Link: https://doi.org/10.7175/..

13

Disease-Modifying Therapies for Multiple Sclerosis: A Syste..:

Iannazzo, Sergio ; Iliza, Ange-Christelle ; Perrault, Louise
PharmacoEconomics. 36 (2017) 2 - p. 189-204 , 2017

Link: https://doi.org/10.1007/..

14

[Cost-effectiveness analysis of delayed-release dimethyl-fu..:

Furneri, Gianluca ; Santoni, Laura ; Marchesi, Chiara...
Farmeconomia. Health economics and therapeutic pathways. 17 (2016) 2 - p. 67-80 , 2016

Link: https://doi.org/10.7175/..

15

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclo..:

Dal Negro, Roberto W. ; Distante, Chiara ; Bonadiman, Luca..
Multidisciplinary Respiratory Medicine. 11 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..